We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
Cap. Flow
+$1.28B
Cap. Flow %
3.53%
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$34.8M
2
AAPL icon
Apple
AAPL
+$33.7M
3
XOM icon
ExxonMobil
XOM
+$30M
4
MSFT icon
Microsoft
MSFT
+$25.3M
5
FTV icon
Fortive
FTV
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Financials 14.59%
3 Healthcare 13.89%
4 Industrials 10.54%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBW icon
2751
Build-A-Bear
BBW
$425M
$150K ﹤0.01%
14,497
+10
+0.1% +$122
PFNX
2752
DELISTED
Pfenex Inc.
PFNX
$147K ﹤0.01%
16,379
+200
+1% +$1.71K
VATE icon
2753
INNOVATE Corp
VATE
$111M
$143K ﹤0.01%
2,632
+50
+2% +$2.3K
EGIO
2754
DELISTED
Edgio, Inc. Common Stock
EGIO
$143K ﹤0.01%
1,913
+48
+3% +$3.24K
SHBI icon
2755
Shore Bancshares
SHBI
$819M
$142K ﹤0.01%
12,012
+1,900
+19% +$22.2K
BSF
2756
DELISTED
Bear State Financial, Inc.
BSF
$142K ﹤0.01%
15,494
+400
+3% +$3.75K
XBKS
2757
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$141K ﹤0.01%
6,095
+2,362
+63% +$49.1K
TOVX icon
2758
Theriva Biologics
TOVX
$9.64M
$140K ﹤0.01%
9
+1
+13% +$15K
FPI
2759
Farmland Partners
FPI
$408M
$139K ﹤0.01%
12,398
+300
+2% +$3.43K
GNMX
2760
DELISTED
Aevi Genomic Medicine Inc
GNMX
$138K ﹤0.01%
24,818
-8,900
-26% -$50.7K
ALT icon
2761
Altimmune
ALT
$552M
$137K ﹤0.01%
157
+31
+25% +$24.3K
HIVE
2762
DELISTED
Aerohive Networks
HIVE
$137K ﹤0.01%
22,511
+420
+2% +$2.82K
ECYT
2763
DELISTED
Endocyte, Inc. Common Stock
ECYT
$137K ﹤0.01%
44,437
+400
+0.9% +$1.25K
PLPM
2764
DELISTED
Planet Payment, Inc
PLPM
$136K ﹤0.01%
36,554
+1,100
+3% +$4.33K
ICD
2765
DELISTED
Independence Contract Drilling, Inc.
ICD
$135K ﹤0.01%
1,288
+35
+3% +$3.54K
HMTV
2766
DELISTED
Hemisphere Media Group, Inc.
HMTV
$135K ﹤0.01%
10,555
-40
-0.4% -$501
GIC icon
2767
Global Industrial
GIC
$1.37B
$134K ﹤0.01%
16,930
+300
+2% +$2.53K
AMRC icon
2768
Ameresco
AMRC
$1.12B
$133K ﹤0.01%
25,364
+500
+2% +$2.48K
CSLT
2769
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$133K ﹤0.01%
32,087
+650
+2% +$2.65K
KONA
2770
DELISTED
Kona Grill, Inc.
KONA
$133K ﹤0.01%
10,613
-1,700
-14% -$21.2K
AVXL icon
2771
Anavex Life Sciences
AVXL
$255M
$129K ﹤0.01%
35,476
+4,100
+13% +$17.3K
TLYS icon
2772
Tilly's
TLYS
$116M
$129K ﹤0.01%
13,712
+200
+1% +$1.47K
INFI
2773
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$129K ﹤0.01%
82,589
+700
+0.9% +$1.07K
NNA
2774
DELISTED
Navios Maritime Acquisition Corporation
NNA
$129K ﹤0.01%
6,347
+140
+2% +$3.09K
NEFF
2775
DELISTED
Neff Corporation
NEFF
$128K ﹤0.01%
13,486
+200
+2% +$1.89K

Similar funds

RhumbLine Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.

  • RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
  • RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
  • RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
  • RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
  • RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
  • RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.